SRL
GMAB icon

Scientech Research LLC’s Genmab GMAB Stock Holding History

Scientech Research LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,109
Closed -$352K – 364
2026
Q1 		$352K Buy
+13,109
New +$393K 0.29% 93
2025
Q4 		– Sell
-10,681
Closed -$328K – 615
2025
Q3 		$328K Sell
10,681
-24,396
-70% -$595K 0.11% 354
2025
Q2 		$725K Buy
35,077
+466
+1% +$9.57K 0.18% 241
2025
Q1 		$678K Buy
34,611
+23,428
+209% +$491K 0.18% 258
2024
Q4 		$233K Buy
+11,183
New +$246K 0.07% 471
2024
Q1 		– Sell
-6,864
Closed -$219K – 467
2023
Q4 		$219K Buy
+6,864
New +$216K 0.22% 226

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Scientech Research LLC's GMAB Position: Q2 2026 in Review

Scientech Research LLC sold out of Genmab (GMAB) in Q2 2026, closing a stake of 13,109 shares — an estimated $352K sold.

Scientech Research LLC first reported a position in GMAB in Q4 2023 and held it in 6 quarters. The position peaked at $725K in Q2 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Scientech Research LLC reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 13,109 Genmab shares in Q2 2026, an estimated $352K.
  • Scientech Research LLC first reported a position in Genmab in Q4 2023 and held it in 6 quarters.
  • Scientech Research LLC's Genmab position peaked at $725K in Q2 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.